JP2022519767A5 - - Google Patents
Info
- Publication number
- JP2022519767A5 JP2022519767A5 JP2021547460A JP2021547460A JP2022519767A5 JP 2022519767 A5 JP2022519767 A5 JP 2022519767A5 JP 2021547460 A JP2021547460 A JP 2021547460A JP 2021547460 A JP2021547460 A JP 2021547460A JP 2022519767 A5 JP2022519767 A5 JP 2022519767A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- composition
- composition according
- agent
- combined mitochondrial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025184569A JP2026048627A (ja) | 2019-02-15 | 2025-10-31 | 心不全の治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962806473P | 2019-02-15 | 2019-02-15 | |
| US62/806,473 | 2019-02-15 | ||
| PCT/US2020/018371 WO2020168247A1 (en) | 2019-02-15 | 2020-02-14 | Treating heart failure |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025184569A Division JP2026048627A (ja) | 2019-02-15 | 2025-10-31 | 心不全の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022519767A JP2022519767A (ja) | 2022-03-24 |
| JP2022519767A5 true JP2022519767A5 (https=) | 2023-02-22 |
| JP7769545B2 JP7769545B2 (ja) | 2025-11-13 |
Family
ID=72044848
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547460A Active JP7769545B2 (ja) | 2019-02-15 | 2020-02-14 | 心不全の治療 |
| JP2025184569A Pending JP2026048627A (ja) | 2019-02-15 | 2025-10-31 | 心不全の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025184569A Pending JP2026048627A (ja) | 2019-02-15 | 2025-10-31 | 心不全の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220160782A1 (https=) |
| EP (1) | EP3923963A4 (https=) |
| JP (2) | JP7769545B2 (https=) |
| CN (1) | CN113710255A (https=) |
| AU (1) | AU2020223358A1 (https=) |
| CA (1) | CA3130213A1 (https=) |
| WO (1) | WO2020168247A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106536056B (zh) | 2014-06-13 | 2021-07-16 | 儿童医学中心公司 | 分离线粒体的产品和方法 |
| US11903974B2 (en) * | 2015-11-30 | 2024-02-20 | Flagship Pioneering Innovations V, Inc. | Methods and compositions relating to chondrisomes from cultured cells |
| WO2017124037A1 (en) | 2016-01-15 | 2017-07-20 | The Children's Medical Center Corporation | Therapeutic use of mitochondria and combined mitochondrial agents |
| WO2025184537A1 (en) * | 2024-03-01 | 2025-09-04 | The Board Of Trustees Of The Leland Stanford Junior University | Bio-engineered mitochondria for targeted delivery to cells |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007011757A1 (en) | 2005-07-14 | 2007-01-25 | Myogen, Inc. | Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart |
| IL183818A0 (en) | 2007-06-10 | 2007-10-31 | Shimon Harpaz | Uniformly abrasive confectionery product and process therefor |
| US20090202606A1 (en) | 2008-01-25 | 2009-08-13 | Viromed Co., Ltd. | Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor |
| WO2013171752A1 (en) * | 2012-05-16 | 2013-11-21 | Minovia Therapeutics Ltd. | Compositions and methods for inducing angiogenesis |
| WO2015073396A1 (en) | 2013-11-12 | 2015-05-21 | The Brigham And Women's Hospital, Inc. | Growth differentiation factor (gdf) for treatment of diastolic heart failure |
| CN106536056B (zh) | 2014-06-13 | 2021-07-16 | 儿童医学中心公司 | 分离线粒体的产品和方法 |
| US11903974B2 (en) | 2015-11-30 | 2024-02-20 | Flagship Pioneering Innovations V, Inc. | Methods and compositions relating to chondrisomes from cultured cells |
| WO2017124037A1 (en) * | 2016-01-15 | 2017-07-20 | The Children's Medical Center Corporation | Therapeutic use of mitochondria and combined mitochondrial agents |
| JP7218897B2 (ja) | 2016-11-16 | 2023-02-07 | ルカ・サイエンス株式会社 | 心不全の治療及び／又は予防に用いるための心筋幹細胞の製造方法 |
-
2020
- 2020-02-14 CA CA3130213A patent/CA3130213A1/en active Pending
- 2020-02-14 WO PCT/US2020/018371 patent/WO2020168247A1/en not_active Ceased
- 2020-02-14 JP JP2021547460A patent/JP7769545B2/ja active Active
- 2020-02-14 CN CN202080028568.8A patent/CN113710255A/zh active Pending
- 2020-02-14 AU AU2020223358A patent/AU2020223358A1/en active Pending
- 2020-02-14 EP EP20756733.0A patent/EP3923963A4/en active Pending
- 2020-02-14 US US17/430,822 patent/US20220160782A1/en active Pending
-
2025
- 2025-10-31 JP JP2025184569A patent/JP2026048627A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022519767A5 (https=) | ||
| Miyamoto et al. | Study Design for a Prospective Randomized Trial of Extracranial-Intracranial Bypass Surgery for Adults With Moyamoya Disease and Hemorrhagic Onset—The Japan Adult Moyamoya Trial Group— | |
| JP2023540485A5 (https=) | ||
| CN109069589B (zh) | 用于心血管病况的司美鲁肽 | |
| Chatterjee et al. | Cardiovascular effects of bretylium tosylate in acute myocardial infarction | |
| Bernstein et al. | Fulminant development of pulmonary arteriovenous fistulas in an infant after total cavopulmonary shunt | |
| Hansson et al. | Comparison of guanadrel and guanethidine | |
| Chou et al. | Myocardial infarction and ischemic hepatitis complicated by postpartum hemorrhage | |
| RU2024122306A (ru) | Лечение сердечной недостаточности | |
| Seltzer et al. | Decrease in arterial pressure following heparin injection prior to cardiopulmonary bypass | |
| Pahuja et al. | Successful Management of Hemodynamically Unstable Takotsubo Cardiomyopathy With Milrinone | |
| RU2021126922A (ru) | Лечение сердечной недостаточности | |
| Unoki et al. | Three cases of LMT-STEMI with cardiogenic shock under ECPELLA support with different levels of left ventricular unloading | |
| Goyal et al. | Anaesthetic considerations for balloon mitral valvuloplasty in pregnant patient with severe mitral stenosis: a case report and review of literature | |
| Rambaud et al. | Extrapericardial cardiac tamponade caused by traumatic retrosternal hematoma | |
| Figueras et al. | Comparative haemodynamic and peripheral vasodilator effects of oral and chewable isosorbide dinitrate in patients with refractory congestive cardiac failure | |
| JP2024527034A5 (https=) | ||
| Maemura et al. | Landiolol dramatically improved Takotsubo cardiomyopathy in an older patient. | |
| Naved et al. | Development of stress-induced cardiomyopathy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy | |
| JP2022528600A (ja) | １型真性糖尿病を有する患者の治療のためのソタグリフロジンの使用 | |
| Nakamura et al. | Initial clinical experience of intravenous tolvaptan sodium phosphate in patients with congestive heart failure | |
| Lim et al. | Recurrent acute decompensated heart failure owing to severe iron deficiency anemia caused by inappropriate habitual bloodletting | |
| Tokudome et al. | Effect of disopyramide on left ventricular pressure gradient in hypertrophic obstructive cardiomyopathy in comparison with propranolol: A case report | |
| Silitonga et al. | Successful Balloon Mitral Valvuloplasty in 21-week Pregnant Patient with Severe Mitral Stenosis: A Case Report and | |
| Nakatani et al. | PS-BPR02-5: A CASE OF JUVENILE-ONSET HYPERTENSION WITH A GIANT LEFT ANTERIOR THORACIC ARTERIOVENOUS FISTULA |